1. Konstas AG, Quaranta L, Bozkurt B, et al. 24-h Efficacy of Glaucoma Treatment Options [published correction appears in Adv Ther. 2016 Apr;33(4):518]. Adv Ther. 2016;33(4):481–517. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846688/pdf/12325_2016_Article_302.pdf2. Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial [published correction appears in Lancet. 2019 Jul 6;394(10192):e1]. Lancet. 2019;393(10180):1505–1516. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495367/?report=reader 3. Garg A, Vickerstaff V, Nathwani N, Garway-Heath D, Konstantakopoulou E, Ambler G, Bunce C, Wormald R, Barton K, Gazzard G; Laser in Glaucoma and Ocular Hypertension Trial Study Group. Efficacy of Repeat Selective Laser Trabeculoplasty in Medication-Naive Open-Angle Glaucoma and Ocular Hypertension during the LiGHT Trial. Ophthalmology. 2020 Apr;127(4):467-476. https://www.aaojournal.org/action/showPdf?pii=S0161-6420%2819%2932181-5 4. Garg A, Vickerstaff V, Nathwani N, Garway-Heath D, Konstantakopoulou E, Ambler G, Bunce C, Wormald R, Barton K, Gazzard G; Laser in Glaucoma and Ocular Hypertension Trial Study Group. Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial. Ophthalmology. 2019 Sep;126(9):1238-1248. https://www.aaojournal.org/action/showPdf?pii=S0161-6420%2819%2930162-9